THYROXINE MICROASSAY— 510(k) K884260

Substantially Equivalent

Diamedix Corp.

FDA 510(k) clearance K884260 for THYROXINE MICROASSAY, Substantially Equivalent on 1989-02-23. Applicant: Diamedix Corp.. Device class: 2.

Clearance details

Applicant: Diamedix Corp.
Product code: Code KLI
Device class: Class 2
Regulation: 21 CFR 862.1700
Advisory panel: Clinical Chemistry
Date received: 1988-10-11
Decision date: 1989-02-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Miami, FL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code KLI

K160495 — VITROS® Automation Solutions2016-10-18
K131515 — ACE -GT REAGENT; ACE LIPASE RAGENT; ACE T4 REAGENT2013-08-14
K103484 — GSP NEONATAL THYROXINE (T4)2011-04-22
K082638 — ADVIA CENTAUR SYSTEM WITH STREAMLAB ANALYTICAL WORKCELL2009-02-26
K030860 — ACCUBIND NEONATAL T4 MICROPLATE EIA, MODEL 2625-3002003-08-22

More clearances from Diamedix Corp.

K093101 — MAGO 4S2011-01-21
K021394 — DIAMEDIX IS-RHEUMATOID FACTOR TEST SYSTEM2002-07-09
K013956 — DIAMEDIX IS-ANTI-B2 GLYCOPROTEIN I SCREEN2002-01-08
K013628 — DIAMEDIX IS-ANTI-B2 GLYCOPROTEIN I IGG/IGM TEST SYSTEM2001-12-21
K012449 — DIAMEDIX IS-ANTI-CARDIOLIPIN IGG/IGM TEST SYSTEM2001-10-26

Data sourced from openFDA. This site is unofficial and independent of the FDA.